Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Epigenetic Clock Marks Age of Human Tissues and Cells

Published: Tuesday, November 05, 2013
Last Updated: Tuesday, November 05, 2013
Bookmark and Share
The age of many human tissues and cells is reflected in chemical changes to DNA. The finding provides insights for cancer, aging, and stem cell research.

We may gauge how we’re aging based on visible changes, such as wrinkles. For years, scientists have been trying to gauge aging based on changes inside our cells.

Many alterations occur to our DNA as we age. Some of these changes are epigenetic—they modify DNA without altering the genetic sequence itself. These changes affect how cells in different parts of the body use the same genetic code. By controlling when specific genes are turned on and off, or “expressed,” they tell cells what to do, where to do it, and when to do it.

One such type of modification occurs when chemical tags known as methyl groups attach to DNA in specific places. This process, known as methylation, affects interactions between DNA and protein-making machinery. Changes in DNA methylation—both increases and decreases—occur with aging.

Dr. Steve Horvath from the University of California, Los Angeles, examined the relationship between DNA methylation and aging. He took advantage of publicly available methylation datasets, including ones from The Cancer Genome Atlas, a joint effort of NIH’s National Cancer Institute (NCI) and National Human Genome Research Institute (NHGRI). The datasets were developed by hundreds of researchers and comprised almost 8,000 samples of 51 healthy tissues and cell types. Samples came from people ranging in age from newborns to 101 years. They included tissues from throughout the body, including the brain, breast, skin, colon, kidney, liver, lung, and heart.

Horvath first developed an age predictor using 39 datasets. The tool was based on 353 specific DNA sites where methyl groups increased or decreased with age. He then tested the predictor in 32 additional datasets. Results appeared in the October 21, 2013, issue of Genome Biology.

Horvath found that the computed biological age based on DNA methylation closely predicted the chronological age of numerous tissues and cells to within just a few years. There were some tissues, however, where the biological age did not match the chronological age. These included skeletal muscle, heart tissue, and breast tissue. The clock also worked well in chimpanzees.

In both embryonic and induced pluripotent stem cells—genetically altered adult cells with characteristics of embryonic stem cells—the DNA methylation age proved to be near zero.

Horvath also analyzed nearly 6,000 samples from 20 different cancers and found that cancer greatly affected DNA methylation age. However, in most cancers the age acceleration didn’t reflect the tumor grade and stage.

The rate of ticking of the biological clock, as measured by the rates of change in DNA methylation, wasn’t constant. It was faster from birth to adulthood, and then slowed to a constant rate around the age of 20.

Horvath didn’t find evidence of a relationship with DNA methylation age in B cells (a type of white blood cell) from people with a premature aging disease (progeria).

“Pinpointing a set of biomarkers that keeps time throughout the body has been a 4-year challenge,” Horvath says. “My goal in inventing this age-predictive tool is to help scientists improve their understanding of what speeds up and slows down the human aging process.”

UCLA has filed a provisional patent on the age-predictive tool, which is freely available to scientists online. Horvath plans to examine whether DNA methylation is only a marker of aging or itself affects aging.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nuclear Transport Problems Linked to ALS and FTD
NIH-supported studies point to potential new target for treating neurodegenerative diseases.
Monday, October 19, 2015
NIH Framework Points The Way Forward For Developing The President’s Precision Medicine Initiative
The NIH Advisory Committee to the Director has presented to NIH Director Francis S. Collins, M.D., Ph.D., a detailed design framework for building a national research participant group, called a cohort, of 1 million or more Americans to expand our knowledge and practice of precision medicine.
Monday, September 21, 2015
Beth Israel Cardiology Team Awarded $3 Million by NIH
Work will help predict outcomes in patients with heart disease.
Friday, September 18, 2015
NIH Awards Nearly $35 Million to Research Natural Products
Innovative Research Centers Program investigates botanical dietary supplements and other natural products.
Thursday, September 10, 2015
Tell-tale Biomarker Detects Early Breast Cancer in NIH-funded Study
The study published online in the issue of Nature Communications.
Thursday, August 13, 2015
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Tuesday, August 04, 2015
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
Monday, August 03, 2015
Vital Protein in Healthy Fertilization Process Identified
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice.
Monday, July 27, 2015
NIH Joins Public-Private Partnership to Fund Research on Autism Biomarkers
Biomarkers Consortium project to improve tools for measuring and treating social impairment in children with autism.
Tuesday, July 21, 2015
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Thursday, July 02, 2015
Linking Targeted Cancer Drugs to Gene Abnormalities
Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.
Wednesday, June 03, 2015
Possible Treatment for Lethal Pediatric Brain Cancer
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death.
Tuesday, May 05, 2015
HIV can Spread Early, Evolve in Patients' Brains
Findings add urgency to screening, treatment - NIH-funded study.
Saturday, March 28, 2015
Test Reliably Detects Inherited Immune Deficiency in Newborns
NIH-supported study suggests that early diagnosis of severe combined immunodeficiency leads to high survival rates.
Thursday, August 21, 2014
NIH Names New Clinical Sites in Undiagnosed Diseases Network
Four-year, $43 million initiative engages broad expertise in study of mystery conditions.
Wednesday, July 02, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos